These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications. Brunklaus A; Brünger T; Feng T; Fons C; Lehikoinen A; Panagiotakaki E; Vintan MA; Symonds J; Andrew J; Arzimanoglou A; Delima S; Gallois J; Hanrahan D; Lesca G; MacLeod S; Marjanovic D; McTague A; Nuñez-Enamorado N; Perez-Palma E; Scott Perry M; Pysden K; Russ-Hall SJ; Scheffer IE; Sully K; Syrbe S; Vaher U; Velayutham M; Vogt J; Weiss S; Wirrell E; Zuberi SM; Lal D; Møller RS; Mantegazza M; Cestèle S Brain; 2022 Nov; 145(11):3816-3831. PubMed ID: 35696452 [TBL] [Abstract][Full Text] [Related]
3. De novo SCN1A pathogenic variants in the GEFS+ spectrum: Not always a familial syndrome. Myers KA; Burgess R; Afawi Z; Damiano JA; Berkovic SF; Hildebrand MS; Scheffer IE Epilepsia; 2017 Feb; 58(2):e26-e30. PubMed ID: 28084635 [TBL] [Abstract][Full Text] [Related]
4. Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies. Mei D; Cetica V; Marini C; Guerrini R Epilepsia; 2019 Dec; 60 Suppl 3():S2-S7. PubMed ID: 31904125 [TBL] [Abstract][Full Text] [Related]
5. Outcomes and comorbidities of SCN1A-related seizure disorders. de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Sinoo C; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH Epilepsy Behav; 2019 Jan; 90():252-259. PubMed ID: 30527252 [TBL] [Abstract][Full Text] [Related]
6. SCN1A/Na Mantegazza M; Broccoli V Epilepsia; 2019 Dec; 60 Suppl 3():S25-S38. PubMed ID: 31904127 [TBL] [Abstract][Full Text] [Related]
7. Mutation spectrum of the SCN1A gene in a Hungarian population with epilepsy. Till Á; Zima J; Fekete A; Bene J; Czakó M; Szabó A; Melegh B; Hadzsiev K Seizure; 2020 Jan; 74():8-13. PubMed ID: 31765958 [TBL] [Abstract][Full Text] [Related]
9. Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication. Matricardi S; Cestèle S; Trivisano M; Kassabian B; Leroudier N; Vittorini R; Nosadini M; Cesaroni E; Siliquini S; Marinaccio C; Longaretti F; Podestà B; Operto FF; Luisi C; Sartori S; Boniver C; Specchio N; Vigevano F; Marini C; Mantegazza M Epilepsia; 2023 May; 64(5):1331-1347. PubMed ID: 36636894 [TBL] [Abstract][Full Text] [Related]
10. SCN1A-related epilepsy with recessive inheritance: Two further families. Moretti R; Arnaud L; Bouteiller D; Trouillard O; Moreau P; Buratti J; Rastetter A; Keren B; Des Portes V; Toulouse J; Gourfinkel-An I; Leguern E; Depienne C; Mignot C; Nava C Eur J Paediatr Neurol; 2021 Jul; 33():121-124. PubMed ID: 34174751 [TBL] [Abstract][Full Text] [Related]
11. [Phenotype and SCN1A gene mutation screening in 39 families with generalized epilepsy with febrile seizures plus]. Xu XJ; Zhang YH; Sun HH; Liu XY; Wu HS; Wu XR Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):580-6. PubMed ID: 23158734 [TBL] [Abstract][Full Text] [Related]
12. SCN1A testing for epilepsy: application in clinical practice. Hirose S; Scheffer IE; Marini C; De Jonghe P; Andermann E; Goldman AM; Kauffman M; Tan NC; Lowenstein DH; Sisodiya SM; Ottman R; Berkovic SF; Epilepsia; 2013 May; 54(5):946-52. PubMed ID: 23586701 [TBL] [Abstract][Full Text] [Related]
13. Homozygous mutations in the SCN1A gene associated with genetic epilepsy with febrile seizures plus and Dravet syndrome in 2 families. Brunklaus A; Ellis R; Stewart H; Aylett S; Reavey E; Jefferson R; Jain R; Chakraborty S; Jayawant S; Zuberi SM Eur J Paediatr Neurol; 2015 Jul; 19(4):484-8. PubMed ID: 25795284 [TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Prediction Model for Early Diagnosis of Brunklaus A; Pérez-Palma E; Ghanty I; Xinge J; Brilstra E; Ceulemans B; Chemaly N; de Lange I; Depienne C; Guerrini R; Mei D; Møller RS; Nabbout R; Regan BM; Schneider AL; Scheffer IE; Schoonjans AS; Symonds JD; Weckhuysen S; Kattan MW; Zuberi SM; Lal D Neurology; 2022 Mar; 98(11):e1163-e1174. PubMed ID: 35074891 [TBL] [Abstract][Full Text] [Related]
16. Defining Dravet syndrome: An essential pre-requisite for precision medicine trials. Li W; Schneider AL; Scheffer IE Epilepsia; 2021 Sep; 62(9):2205-2217. PubMed ID: 34338318 [TBL] [Abstract][Full Text] [Related]
17. Mosaicism of de novo pathogenic SCN1A variants in epilepsy is a frequent phenomenon that correlates with variable phenotypes. de Lange IM; Koudijs MJ; van 't Slot R; Gunning B; Sonsma ACM; van Gemert LJJM; Mulder F; Carbo EC; van Kempen MJA; Verbeek NE; Nijman IJ; Ernst RF; Savelberg SMC; Knoers NVAM; Brilstra EH; Koeleman BPC Epilepsia; 2018 Mar; 59(3):690-703. PubMed ID: 29460957 [TBL] [Abstract][Full Text] [Related]